The aim of this study was to evaluate 1000 LDL-apheresis procedures performed in 9 patients with severe familial lipid disorder. LDL-apheresis is a method of extracorporeal elimination of LDL-cholesterol, based on immunoadsorption and used in severe hyperlipidemia patients, refractory to conventional treatment.